Novo Nordisk confirms start of phase I robotic pill trial
In its Q1 report, the pharmaceutical company revealed that the phase I trial of its SOMA capsule has begun.
by christopher due karlsson, translated by catherine brett
Novo Nordisk has confirmed that it has started a phase I trial of its SOMA robotic pill, currently known as DV3395.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk initiates phase I trial of oral device
For subscribers
Novo Nordisk remains coy over Wegovy blockbuster potential
For subscribers
